News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Turner Christopher Durant
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Turner Christopher Durant (Chief Medical Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 2,665 shares
@ $51.32, valued at
$136.8k
Sold 2,265 shares
@ $53.7, valued at
$121.6k
Sold 600 shares
@ $54.32, valued at
$32.6k
Sold 500 shares
@ $55.84, valued at
$27.9k
Sold 500 shares
@ $57.18, valued at
$28.6k
Sold 1,465 shares
@ $57.7, valued at
$84.5k
Exercised 7,995 options to buy
@ $6.89, valued at
$55.1k
|
|
| 07/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2023 |
4
| Turner Christopher Durant (Chief Medical Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 10,235 shares
@ $44.86, valued at
$459.1k
Exercised 10,235 options to buy
@ $6.89, valued at
$70.5k
|
|
| 01/06/2023 |
4
| Turner Christopher Durant (Chief Medical Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 144,200 options to buy
@ $27.85, valued at
$4M
|
|
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Turner Christopher Durant (Chief Medical Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 107,000 options to buy
@ $18.93, valued at
$2M
|
|
| 07/28/2021 |
3
| Turner Christopher Durant (Chief Medical Officer) has filed a Form 3 on Nuvalent, Inc. |
|
|